Catalyst Wire Dossier Catalyst Wire Dossier

SHetA2

SHetA2 · University of Oklahoma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHetA2, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Advanced or Recurrent Solid Tumors Treated With SHetA2 [Phase 1]

See pricing